First Fast PCR Saliva COVID-19 Tests for Point of Care Conducted in Canada - Read Press Release

Hyris bCUBE RT-qPCR Test

Employee operating PCR device

Hyris bCUBE RT-qPCR Test

Hyris bCUBE, as a RT-qPCR-based device, it is unmatched for its high sensitivity, often detecting infection in asymptomatic carriers. Authorized by Health Canada for point-of-care (onsite) testing in September 2020, the bCUBE is the chosen testing device by leading Canadian businesses, organizations, and communities, including the Province of Manitoba.

Up to 16 samples

per testing cycle

Stopwatch icon

Quick results

120 minutes per analysis

Target icon

99% specificity

100% sensitivity

PCR tests are ideal for controlled environments

PCR rapid tests are ideal for controlled
environments where an outbreak will have severe
economic and/or health impacts. This includes sports
tournaments, mining operations and remote

Find out if the Hyris bCUBE PCR device should be part of a point-of-care testing solution for your specific environment and population.